Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 2/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17548202 | 0.88 | FFAR1 (0.40) | MEN1POLBKMT2AADORA2A | |
| SCHEMBL12129683 | 0.84 | CYP1A2 (0.36) | MEN1POLBKMT2AADORA2ATYMS | |
| SCHEMBL10035470 | 0.71 | TYMS (0.41) | MEN1POLBKMT2ATYMS | |
| SCHEMBL15327084 | 0.70 | MAOA (0.47) | POLB | |
| SCHEMBL3448095 | 0.67 | MAOA (0.51) | POLB | |
| SCHEMBL31257143 | 0.67 | STK10 (0.40) | POLBKMT2AADORA2A | |
| SCHEMBL148025 | 0.66 | TYMS (0.62) | MEN1POLBKMT2ATYMS | |
| SCHEMBL18068778 | 0.66 | GSTP1 (0.37) | MEN1POLBKMT2AADORA2ATYMS | |
| SCHEMBL23430836 | 0.65 | MCL1 (0.56) | MEN1POLBKMT2ATYMS | |
| SCHEMBL18071038 | 0.62 | PARP1 (0.32) | TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106142-B2 | Polyacetylinic oligomers | THE BOEING COMPANY (US) | 2012-01-31 | — | — | US | disclosed |
| US-8063168-B2 | Oligomers with di-phenylethynyl endcaps | THE BOEING COMPANY (US) | 2011-11-22 | — | — | US | disclosed |
| US-20100204412-A1 | OLIGOMERS WITH DI-PHENYLETHYNYL ENDCAPS | THE BOEING COMPANY | 2010-08-12 | — | — | US | disclosed |
| US-20100204485-A1 | POLYACETYLINIC OLIGOMERS | THE BOEING COMPANY | 2010-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204485-A1 | POLYACETYLINIC OLIGOMERS | AADAC, ACMSD, ECPAS | MEN1 4503/4885POLB 3179/4885KMT2A 1850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.